Drug shortages remain low in 2021 as FDA's prevention efforts grow, report to Congress says
Supply chain snafus, high-profile drug and vaccine shortages and quality issues (e.g. Emergent’s Baltimore site) have played a major role during the pandemic so far. But in a new report to Congress, the FDA said that it’s continuing to see drug shortages decline — from a high of 250 drug shortages in 2011 to just 41 in 2021.
“The number of new drug shortages has not increased significantly during the COVID-19 pandemic,” FDA said. However, the agency also made clear that in 2021, “there were shortages of drug products from manufacturers in the U.S. and abroad, and there continues to be concern surrounding the supply chain and reliance on overseas manufacturing.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
